Interventional Oncology: Exploring the Boundaries

In This Issue

Guest Chief Medical Editor Edward Kim, MD, introduces our latest issue on interventional oncology (IO), which evaluates the recent evolutions in treatment, including advances in techniques and upcoming technologies.

Cover Stories

Drs. Christopher D. Malone and Tyler Sandow spotlight five recent IO studies and posit why each is significant, both in the context of the study itself and the bigger picture of the IO field as a whole.

Beau B. Toskich, MD, surveys Rony Avritscher, MD; Kirema Garcia-Reyes, MD; and Nora Tabori, MD, about their insights and opinions on combining locoregional and immunotherapy.

Jin Woo Choi, MD, and Riad Salem, MD, ponder the optimal timing for transarterial radioembolization in advanced HCC. They talk about current data and clinical experience, when this treatment option may increase the likelihood of curative outcomes in this specific patient population, and when radioembolization might not be beneficial.

Jack Jennings, MD, tackles musculoskeletal ablation, with a review of the path to treatment, current technology and advancement, and next steps for interventionalists to best serve these patients.

Drs. Omid Shafaat, Junaid Y. Raja, Noreen Siddiqi, Abin M. Sajan, and Venkatesh P. Krishnasamy reflect on liver ablation, reviewing the standard practice and looking at current and future advances in ablation technology for liver tumor treatment.

Ronak Patel, BS, and Merve Ozen, MD, highlight renal ablation and the advancements in technique and approach that allow for precise strategies based on tumor stage.

Departments

We interview vascular surgeon Marie Josee van Rijn, MD, about her epidemiology background, the multidisciplinary nature of deep venous thrombosis treatment, and tips for postthrombectomy acute iliofemoral venous thrombosis stenting.

Current Supplement

Recognized experts in carotid artery disease discuss the newly FDA-approved Neuroguard IEP® System, insights into the data, and the impact on the field. | Sponsored by Contego Medical, Inc.